🧪Cytisinicline reduces symptoms of nicotine craving and withdrawal. If approved in June 2026, it will be the first new approved pharmacotherapy for smoking cessation in 20 years.
psychiatrictimes.com
FDA Accepts New Drug Application for Cytisinicline for Smoking Cessation
Achieve Life Sciences gains FDA acceptance for cytisinicline, a promising new drug for smoking cessation, showing significant abstinence rates in trials.